IRIS
PARODI, SILVIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.110
Totale 5.110
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 5.110
Totale 5.110
Salva come PNG Salva come JPEG
Città #
Genova 3.753
Rapallo 557
Genoa 550
Vado Ligure 242
Bordighera 8
Totale 5.110
Salva come PNG Salva come JPEG
Nome #
Internalization via Antennapedia protein transduction domain of an scFv antibody toward c-Myc protein 168
Advances in dynamic modeling of colorectal cancer signaling-network regions, a path toward targeted therapies. 160
A novel Bim-BH3-derived Bcl-X(L) inhibitor: Biochemical characterization, in vitro, in vivo and ex-vivo anti-leukemic activity 158
Role of angiogenesis inhibitors in colorectal cancer: sensitive and insensitive tumors. 158
Systems medicine in colorectal cancer: from a mathematical model toward a new type of clinical trial 153
Ras-induced resistance to lapatinib is overcome by MEK inhibition 149
Patient-tailored treatments with anti-EGFR monoclonal antibodies in advanced colorectal cancer: KRAS and beyond. 147
A multi-scale approach to colorectal cancer: from a biochemical- interaction signaling-network level, to multi-cellular dynamics of malignant transformation. Interplay with mutations and onco-protein inhibitor drugs. 147
Unraveling the organization of the Internal Nuclear Matrix: RNA-Dependent Anchoring of NuMa to a Lamin Scaffold. 142
DNA DAMAGE IN LIVER, COLON, STOMACH, LUNG AND KIDNEY OF BALB/C MICE TREATED WITH 1,2-DIMETHYLHYDRAZINE. 140
Cellular effects of a new farnesyltransferase inhibitor, RPR-115135, in a human isogenic colon cancer cell line model system HCT-116 136
Drug metabolism polymorphisms as modulators of cancer susceptibility. 135
Differential expression of nuclear lamins in normal and cancerous prostate tissues 135
Intracystic epidermal growth factor level is predictive of breast-cancer risk in women with gross cystic disease of the breast 133
A retro-inverso peptide homologous to helix 1 of c-Myc is a potent and specific inhibitor of proliferation in different cellular systems. 132
Parameter Space Exploration within Dynamic Simulations of Signaling Networks 131
Inhibition of a protein-protein interaction between INI1 and c-Myc by small peptidomimetic molecules inspired by Helix-1 of c-Myc: Identification of a new target of potential antineoplastic interest 130
Dynamic simulations of pathways downstream of ERBB-family, including mutations and treatments. Concordance with experimental results. 122
A computerized connectivity approach for analyzing the structural basis of mutagenicity in Salmonella and its relationship with rodent carcinogenicity 121
Analysis of publication quality in a Cancer Research Institute. 119
Changes in the expression of cytokeratins and nuclear matrix proteins are correlated with the level of differentiation in human prostate cancer 118
A decision support system for the prediction of carcinogenic activity of organic chemical compounds 118
Dynamic Simulations of Pathway Cross-talks Relevant in Colorectal Cancer: A Quantitative Parameter Sensitivity Analysis 117
Molecular Interaction Maps - A Diagrammatic Graphical Language for Bioregulatory Networks. 115
Tumor-Necrosis-Factor and DNA topoisomerase-II inhibitors in human ovarian-cancer - Potential role in chemotherapy 113
ALKALINE ELUTION ASSAY AS A POTENTIALLY USEFUL METHOD FOR ASSESSING DNA DAMAGE INDUCED "IN VIVO" BY DIAZOALKANES. 111
Potent synergistic interaction between the Nampt inhibitor APO866 and the apoptosis activator TRAIL in human leukemia cells. 109
Iron overload detection in rats by means of a susceptometer operating at room temperature 107
Systems medicine in oncology: Signaling network modeling and new-generation decision-support systems 107
Molecular fragments associated with non genotoxic carcinogens, as detected using a software program based on graph theory: their usefulness to predict carcinogenicity 106
Relationship between molecular connectivity and carcinogenic activity: a confirmation with a new software program based on graph theory 104
Apoptosis of B-cell chronic lymphocytic leukemia cells induced by a novel BH3 peptidomimetic 103
Effects of Parameter Space Exploration within Dynamic Simulations of Pathways Downstream of Erbb-family on Breast Cancer 99
Sequence specific peptidomimetic molecules inhibitors of a protein-protein interaction at the helix 1 level of c-Myc 96
Inhibition of cancer cell growth and c-Myc transcriptional activity by a c-Myc helix 1-type peptide fused to an internalization sequence. 88
Structural investigation of proapoptotic peptide by CD and NMR spectroscopy 87
Design, synthesis and activity of inverso peptides interacting with c-Myc and Bcl-XL 85
Structural characterization of Int and Int-H1 peptides by Circular Dichroism and NMR spectroscopy 84
Nuclear matrix proteins changes in cancerous prostate tissue and their prognostic value in clinically localized prostate cancer 77
DNA-DAMAGING ACTIVITY "IN VIVO" AND BACTERIAL MUTAGENICITY OF SIXTEEN HYDRAZINE DERIVATIVES AS RELATED QUANTITATIVELY TO THEIR CARCINOGENICITY. 76
"Solution structure investigation of Int-H1 peptide could support the functional significance of a proapoptotic sequence” 73
A circular channel crucible oscillating viscometer. Detection of DNA damage induced "in vivo" by exceedingly small doses of dimethylnitrosamine 68
Potent Synergistic Activity of the NAD plus Synthesis Inhibitor APO866 and of the Apoptosis Inducer TRAIL in in Vitro and Ex Vivo Cellular Models of Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia. 63
Meta-Analysis of the role of p53 status in isogenic systems tested for sensitivity to cytotoxic antoneoplastic drugs 60
Computational quantification of global effects induced by mutations and drugs in signaling networks of colorectal cancer cells 58
Totale 5.158
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.192
article - articoli 12.456
book - libri 271
conference - conferenze 1.146
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 319
Totale 28.384
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.005 0 0 0 0 122 131 177 78 106 210 131 50
2020/2021389 23 30 44 31 34 57 23 26 34 32 31 24
2021/2022548 18 48 31 64 22 35 38 126 15 64 21 66
2022/2023670 64 66 0 100 102 108 9 36 101 6 71 7
2023/2024414 16 32 12 44 30 154 14 12 11 12 17 60
2024/2025275 43 65 19 84 64 0 0 0 0 0 0 0
Totale 5.158